L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.
Frequently asked questions
What sector does L&C Bio Co. Ltd (290650) operate in?
L&C Bio Co. Ltd belongs to the Energy sector and operates in the Medical Devices industry.
What is L&C Bio Co. Ltd (290650) current stock price?
As of the latest data, L&C Bio Co. Ltd stock price is ₩54,700, with a previous close of ₩56,800. L&C Bio Co. Ltd lost -₩2,100 in the last trading session, representing a -3.7% loss.
What is L&C Bio Co. Ltd (290650) current market capitalization?
L&C Bio Co. Ltd market cap is approximately 1.35 trillion.
Does L&C Bio Co. Ltd (290650) pay dividends?
Yes. L&C Bio Co. Ltd pays annual dividends with an annualized yield of 0.05% and an estimated annual payout of ₩25 per share.
When is the next ex-dividend date for L&C Bio Co. Ltd (290650)?
The next ex-dividend date is scheduled for December 29, 2026.
What is L&C Bio Co. Ltd (290650) beta (volatility) score?
L&C Bio Co. Ltd has a beta of 1.492, suggesting it is more volatile than the market.